The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Adamed Pharma competitive analysis

Loading summary...

Latest oppositions filed by Adamed Pharma

Explore patent oppositions filed by Adamed Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3697392
Tablets Comprising Tamsulosin And SolifenacinSYNTHONAug 9, 2024
EP2959894
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJul 11, 2023

Latest patents of Adamed Pharma opposed by its competitors

Explore Adamed Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3749286
Oct 23, 2024A Pharmaceutical Composition Comprising Metamizole, Drotaverine, And Caffeine1
EP2919815
Sep 6, 2017A Pharmaceutical Composition Containing An Ace Inhibitor And A Calcium Channel Blocker1

Latest PTAB cases involving Adamed Pharma

Discover the latest PTAB cases involving Adamed Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adamed Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ADAMED PHARMA22 - -
HOFFMANN EITLE148 - - -
MEDITOP GYOGYSZERIPARI KFT1 - - -
NOVARTIS6422 - 21